Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
about
Everolimus-eluting stents in interventional cardiologyComing safely to a stop: a review of platelet activity after cessation of antiplatelet drugsDuration of dual antiplatelet treatment in the era of next generation drug-eluting stentsApplications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?Optimal Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: Shorter or Longer?Perioperative management of patient with intracoronary stent presenting for noncardiac surgeryDual antiplatelet therapy and drug eluting stents: a marriage of convenienceConstruction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogenC(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured ArteriesDrug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter RegistryDrug-eluting stents in patients with chronic kidney disease: a prospective registry studyRapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cellsRETRACTED: Drug-eluting stents for acute coronary syndrome: a meta-analysis of randomized controlled trialsSurface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower ThrombogenicityOutcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression.Reducing Neointima Formation in a Swine Model with IVUS and Sirolimus Microbubbles.Focused in vivo delivery of plasmid DNA to the porcine vascular wall via intravascular ultrasound destruction of microbubblesThe invasive assessment of coronary atherosclerosis and stents using optical coherence tomography: a clinical updateComparison of acute recoil between bioabsorbable poly-L-lactic acid XINSORB stent and metallic stent in porcine modelClopidogrel: the data, the experience, and the controversies.Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expressionBorderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.Patient-Centered Tablet Application for Improving Medication Adherence after a Drug-Eluting Stent.Biodegradable Cable-Tie Rapamycin-eluting Stents.Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data RegistryDiagnostic Performance of Coronary CT Angiography, Stress Dual-Energy CT Perfusion, and Stress Perfusion Single-Photon Emission Computed Tomography for Coronary Artery Disease: Comparison with Combined Invasive Coronary Angiography and Stress PerfusVascular response profiles following a nano polymer-free sirolimus-eluting stent implantation assessed by optical coherence tomography in a porcine modelLong-term clinical outcomes after drug-eluting and bare-metal stenting in MassachusettsPreclinical study of a biodegradable polymer-based stent with abluminal sirolimus release.Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC studyIn vivo study on the histocompatibility and degradation behavior of biodegradable poly(trimethylene carbonate-co-D,L-lactide).Efficacy of sirolimus-eluting stents compared with paclitaxel-eluting stents in an unselected population with coronary artery disease: 24-month outcomes of patients in a prospective non-randomized registry in Southern Turkey.Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry[Coronary intervention. 2012 update].Ureteroscopy in patients with coagulopathies is associated with lower stone-free rate and increased risk of clinically significant hematuria.Efficacy and safety of drug-eluting stents in the real world: 8-year follow-up.A meta-analysis of the impact of EPC capture stent on the clinical outcomes in patients with coronary artery disease.
P2860
Q24630321-609D6053-EFAA-49B4-8AC3-B95788E30752Q26795403-224CE2E8-67AB-4EF2-B180-24D7089D2FB9Q26830266-F7A824B1-40A4-4ED7-8B62-DEE8F4801658Q26849372-5FD5AECC-E5AA-4961-B903-C1AF032D6E41Q26852812-B6BCD9C1-3169-4801-8EDC-8A6903BA5396Q28075834-0CCCF835-9315-4712-B277-7913071CA3FCQ28222394-CF1A62C2-80B4-40F2-8464-DD457CA7F732Q28222949-CC854464-27E4-48FD-ADD9-BC08513663AAQ28392226-1BE4544A-00B5-4660-BE86-00EB11CB6032Q28468707-7572F24D-2DC8-4FC6-B64E-9D1831579EF7Q28476360-0AEEE023-C3AC-49B1-8594-D2B84AE6959AQ28482627-59EDE60B-4476-47ED-A027-92E5D629C13AQ28536811-797C5BE4-0EC2-4D12-83B6-51E4628957E0Q28551353-1EF3FFE1-9317-4AB2-B433-55944501BAA2Q30239889-0CEFA247-C99A-4886-8E84-DEC6BA2E3B12Q30300162-14AADB7F-1796-4608-9C66-0F5ED2FC6904Q30432859-160FAFBF-531B-48A9-BBA6-6C940805EC7EQ30442855-E12A01C4-6900-48DA-B366-E150A3031197Q30462302-79B02AC0-DD18-41B4-8324-E543B8F26FD4Q30573045-D0A77510-7110-4D00-8418-49973052F6C7Q30575327-6DE3A732-2447-4E5A-9603-5A7F2C73DDF2Q30667055-A672732E-EE27-4789-B02F-34E6A5075664Q30831522-F65ABFA6-A4FB-4C50-8860-FDBB3A6C56B7Q30849379-AB8EDFA2-1E40-41E4-AC97-70A8E891F90EQ30910604-256BCE62-F25A-47B1-B0E7-EFB73587965AQ33378066-D0E8AED8-68D5-4B5F-8322-9D7D50BC3D89Q33437306-EFDB4B44-A1C0-489D-8691-BCF503D5414DQ33561398-9EE09724-3644-466E-8080-C98ADFD673FCQ33598021-B0C519D2-1309-4443-AAA1-B58C25274C18Q33649631-E0AE396D-2432-4429-926E-02E8C4C2783CQ33733393-F6F6E1AB-334C-45B8-AC56-06C3731E0B2CQ33849056-2501CCD5-340C-4F52-A9A8-31081CE856C5Q33893919-0297A97C-4366-497E-B738-76C1D44060BEQ33899822-6795849F-F600-4D84-AF41-DAA74D9E84A3Q33949407-5861F372-C489-411F-B20E-B8C7B4AE5733Q34126291-41455304-5D41-47C2-A541-0416845CCC63Q34180883-E3449634-ED1E-449D-A35B-041594B42709Q34255256-F8B4D20E-74FB-4BA3-8FB7-C69C6041B0C5Q34319885-5667B0B2-0D82-4CF9-91B5-C6D77DA3E7D7Q34577347-3055AC13-E584-42D1-9FFF-14D37B7779B6
P2860
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Late clinical events after clo ...... ting versus bare-metal stents.
@en
Late clinical events after clo ...... ting versus bare-metal stents.
@nl
type
label
Late clinical events after clo ...... ting versus bare-metal stents.
@en
Late clinical events after clo ...... ting versus bare-metal stents.
@nl
prefLabel
Late clinical events after clo ...... ting versus bare-metal stents.
@en
Late clinical events after clo ...... ting versus bare-metal stents.
@nl
P2093
P1476
Late clinical events after clo ...... ting versus bare-metal stents.
@en
P2093
BASKET-LATE Investigators
Christian Mueller
Christoph Kaiser
Franziska Bader
Hans Peter Brunner-La Rocca
Matthias Pfisterer
Patrick Hunziker
Peter Rickenbacher
Peter T Buser
Raban Jeger
P304
P356
10.1016/J.JACC.2006.10.026
P407
P577
2006-11-02T00:00:00Z